Medical Oncology 

The Medical Oncology Program at the University of Tennessee Medical Center provides inpatient, outpatient and consultative services for the treatment of solid tumors and malignant hematologic conditions such as leukemia and lymphoma. Our multidisciplinary team involves board certified cancer specialists, nurses, pharmacists and support staff that coordinate individualized care plans for patients with cancer and blood disorders. 

As part of the Cancer Institute, patients also have access to cutting-edge clinical trials offering the latest available cancer treatments. In addition, we offer patients a wide range of supportive care resources. 

Medical oncology services are available at satellite office locations in the Knoxville and surrounding counties of Blount, Sevier, and Loudon for the convenience of our patients.

For more information or to schedule an appointment, please call:

Treatment Options

Our team looks at the person as a whole and designs a medical care plan to meet their needs.  Several key factors, such as the type and stage of the cancer, as well as age, health, and lifestyle are considered when determining each treatment plan which may include:   

 

Clinical Trials

Clinical trials are research studies made available to patients that offer the newest treatments and test new ways to prevent, detect, diagnose and treat diseases. For more information, visit the Clinical Trials page or call 865.305.9773.

 Specialists

Medical Oncologists


At the University of Tennessee Medical Center, our board certified medical oncologists are experts in the diagnosis, evaluation and treatment of cancer including solid tumors and hematologic malignancies such as leukemia and lymphoma.  A medical oncologist is a physician who specializes in the medical treatment of cancer with chemotherapy as well as biological and hormonal therapy. Our medical oncologists work closely with the multidisciplinary oncology team to determine an individualized care plan and to coordinate the patient’s care.  Evidence based treatment guidelines from the National Comprehensive Cancer Network (NCCN) and other peer-reviewed, nationally recognized organizations are used as guidelines to ensure adherence to clinical practice standards (“best practices”) and to optimize the quality of care and patient outcomes.